ASSESSMENT OF THE EFFICACY OF COMBINATION THERAPY BUDESONIDE/FORMOTEROL FUMARATE (BUFOMIX EASYHALER 160/4.5 µG OR 320/9.0 µG PER INHALATION) IN PATIENTS DIAGNOSED WITH ASTHMA (ORN/AST/2016/004) First published 13/12/2016 Last updated 31/03/2024 EU PAS number:EUPAS16451 Study Finalised